01/30/2026
Tell them what you think ! The FDA is taking a fresh look at how testosterone replacement therapy (TRT) is labeled and regulated. They have opened a public comment period to gather real-world experiences with TRT.
Patients and clinicians are invited to share their stories and submit comments directly to the FDA. Public comment is one of the best direct ways to help inform regulatory decisions.
For those who want to contribute, the comment window closes on February 9th. https://www.federalregister.gov/documents/2025/12/11/2025-22466/food-and-drug-administration-expert-panel-on-testosterone-replacement-therapy-for-men-request-for